Literature DB >> 15673516

Immunological properties of surface proteins of Clostridium difficile.

Séverine Péchiné1, Aude Gleizes1, Claire Janoir1, Roseline Gorges-Kergot1, Marie-Claude Barc1, Michel Delmée1, Anne Collignon1.   

Abstract

Sera from patients with Clostridium difficile-associated disease (CDAD) and sera from a control group were analysed by an ELISA to detect antibodies directed against four surface proteins and toxins A and B of C. difficile. The surface proteins were the flagellar cap protein FliD, the flagellin FliC, the adhesin Cwp66 divided into two domains, Cwp66-Nterminal and Cwp66-Cterminal, and the fibronectin-binding protein Fbp68. For each antigen, antibody levels in the CDAD patient group and in the control group were compared. In the CDAD patient group, the mean of the antibody levels decreased from Cwp66-Cterminal to Fbp68, FliD, toxins B and A, Cwp66-Nterminal and finally FliC, suggesting different immunogenic properties among these adhesins. For Cwp66-Nterminal, FliC, FliD and Fbp68, the antibody level observed in the control group was higher than in the CDAD group with a statistically significant difference whereas the antibody level for toxins A and B was not statistically different. In conclusion, this study suggests that during the clinical course of disease, C. difficile adhesins are able to induce an immune response which could play a role in the defence mechanism of the host.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673516     DOI: 10.1099/jmm.0.45800-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  34 in total

Review 1.  Immune-based treatment and prevention of Clostridium difficile infection.

Authors:  Song Zhao; Chandrabali Ghose-Paul; Keshan Zhang; Saul Tzipori; Xingmin Sun
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Variability of Clostridium difficile surface proteins and specific serum antibody response in patients with Clostridium difficile-associated disease.

Authors:  Séverine Péchiné; Claire Janoir; Anne Collignon
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Cwp22, a novel peptidoglycan cross-linking enzyme, plays pleiotropic roles in Clostridioides difficile.

Authors:  Duolong Zhu; Jessica Bullock; Yongqun He; Xingmin Sun
Journal:  Environ Microbiol       Date:  2019-06-28       Impact factor: 5.491

4.  TPL2 Is a Key Regulator of Intestinal Inflammation in Clostridium difficile Infection.

Authors:  Yuanguo Wang; Shaohui Wang; Ciaran P Kelly; Hanping Feng; Andrew Greenberg; Xingmin Sun
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

Review 5.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

6.  Clostridium difficile has two parallel and essential Sec secretion systems.

Authors:  Robert P Fagan; Neil F Fairweather
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

7.  Mutagenic analysis of the Clostridium difficile flagellar proteins, FliC and FliD, and their contribution to virulence in hamsters.

Authors:  Tanis C Dingle; George L Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2011-07-25       Impact factor: 3.441

8.  Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing.

Authors:  Kate E Dingle; Xavier Didelot; M Azim Ansari; David W Eyre; Alison Vaughan; David Griffiths; Camilla L C Ip; Elizabeth M Batty; Tanya Golubchik; Rory Bowden; Keith A Jolley; Derek W Hood; Warren N Fawley; A Sarah Walker; Timothy E Peto; Mark H Wilcox; Derrick W Crook
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

Review 9.  The host immune response to Clostridium difficile infection.

Authors:  Katie Solomon
Journal:  Ther Adv Infect Dis       Date:  2013-02

10.  Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.

Authors:  Cécile Denève; Sylvie Bouttier; Bruno Dupuy; Frédéric Barbut; Anne Collignon; Claire Janoir
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.